估值600多亿，马斯克的超级独角兽又融资了

Core Viewpoint - Neuralink, founded by Elon Musk, has successfully raised $600 million in funding, achieving a pre-money valuation of $9 billion, marking its status as a super unicorn after nine years of development [3][10]. Funding and Growth - Neuralink has raised over $1.2 billion in total funding since its inception in 2016, with significant contributions from various investors including Founders Fund, DFJ Growth, Google Ventures, and Vy Capital [3][8][10]. - The company completed its Series D funding round with $280 million led by Founders Fund, followed by an additional $43 million in a D round extension [10]. Technological Advancements - Neuralink has developed a brain-machine interface (BCI) device capable of implanting 1,024 electrode wires into the brain to collect signals, which can then be transmitted wirelessly to external devices [5][6]. - The company has conducted successful animal trials and has recently begun human clinical trials, with three patients already implanted with the device [4][6]. Market Potential - The global market for brain-machine interfaces in the medical field is projected to grow significantly, with estimates suggesting a potential market size increase from $40 billion in 2030 to $145 billion by 2040 [14]. Industry Landscape - The brain-machine interface sector in China is rapidly evolving, with numerous companies such as Qiangnao Technology, Zhiruan Medical, and others making notable advancements [12][13]. - Major investment firms like Sequoia China and Hillhouse Capital have entered the brain-machine interface space, indicating strong interest and potential for growth in this emerging field [11][13].